Search research articles
Contact Us
Filters
Showing results (181-190 of 209) with videos related to
Page
of 21
Sort By:
The New England Journal of Medicine
|
October 1, 1992
The heart in hypertension
E D Frohlich, C Apstein, A V Chobanian, et al.
European Journal of Pharmacology
|
June 15, 1993
Pseudoirreversible binding characteristics of [D-Ala2,Glu4]deltorphin and its Cys4 substituted derivative to delta-opioid receptors
K D Wild, P J Horan, A Misicka, et al.
Iscience
|
October 5, 2019
Lrp4 Mediates Bone Homeostasis and Mechanotransduction through Interaction with Sclerostin In Vivo
Whitney A Bullock, April M Hoggatt, Daniel J Horan, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
October 15, 2019
YAP and TAZ Mediate Osteocyte Perilacunar/Canalicular Remodeling
Christopher D Kegelman, Jennifer C Coulombe, Kelsey M Jordan, et al.
Journal of Medicinal Chemistry
|
May 27, 1994
[L-Ala3]DPDPE: a new enkephalin analog with a unique opioid receptor activity profile. Further evidence of delta-opioid receptor multiplicity
R C Haaseth, P J Horan, E J Bilsky, et al.
Bone
|
September 3, 2023
Loss of Nmp4 enhances bone gain from sclerostin antibody administration
Crystal Korff, Michele Adaway, Emily G Atkinson, et al.
Hypertension (Dallas, Tex. : 1979)
|
September 1, 1985
NIH report on research challenges in nutrition and hypertension
M J Horan, M P Blaustein, J B Dunbar, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
February 7, 2018
Skeletal cell YAP and TAZ combinatorially promote bone development
Christopher D Kegelman, Devon E Mason, James H Dawahare, et al.
Science Translational Medicine
|
November 15, 2013
Sclerostin inhibition reverses skeletal fragility in an Lrp5-deficient mouse model of OPPG syndrome
Rajendra Kedlaya, Shreya Veera, Daniel J Horan, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 1, 1993
Agonist and antagonist profiles of [D-Ala2,Glu4]deltorphin and its [Cys4]- and [Ser4]-substituted derivatives: further evidence of opioid delta receptor multiplicity
P J Horan, K D Wild, A Misicka, et al.
Page
of 21
Search research articles
Search
Showing results (181-190 of 209) with videos related to
Sort By:
Page
of 21
The New England Journal of Medicine
|
October 1, 1992
The heart in hypertension
E D Frohlich, C Apstein, A V Chobanian, et al.
European Journal of Pharmacology
|
June 15, 1993
Pseudoirreversible binding characteristics of [D-Ala2,Glu4]deltorphin and its Cys4 substituted derivative to delta-opioid receptors
K D Wild, P J Horan, A Misicka, et al.
Iscience
|
October 5, 2019
Lrp4 Mediates Bone Homeostasis and Mechanotransduction through Interaction with Sclerostin In Vivo
Whitney A Bullock, April M Hoggatt, Daniel J Horan, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
October 15, 2019
YAP and TAZ Mediate Osteocyte Perilacunar/Canalicular Remodeling
Christopher D Kegelman, Jennifer C Coulombe, Kelsey M Jordan, et al.
Journal of Medicinal Chemistry
|
May 27, 1994
[L-Ala3]DPDPE: a new enkephalin analog with a unique opioid receptor activity profile. Further evidence of delta-opioid receptor multiplicity
R C Haaseth, P J Horan, E J Bilsky, et al.
Bone
|
September 3, 2023
Loss of Nmp4 enhances bone gain from sclerostin antibody administration
Crystal Korff, Michele Adaway, Emily G Atkinson, et al.
Hypertension (Dallas, Tex. : 1979)
|
September 1, 1985
NIH report on research challenges in nutrition and hypertension
M J Horan, M P Blaustein, J B Dunbar, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
February 7, 2018
Skeletal cell YAP and TAZ combinatorially promote bone development
Christopher D Kegelman, Devon E Mason, James H Dawahare, et al.
Science Translational Medicine
|
November 15, 2013
Sclerostin inhibition reverses skeletal fragility in an Lrp5-deficient mouse model of OPPG syndrome
Rajendra Kedlaya, Shreya Veera, Daniel J Horan, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 1, 1993
Agonist and antagonist profiles of [D-Ala2,Glu4]deltorphin and its [Cys4]- and [Ser4]-substituted derivatives: further evidence of opioid delta receptor multiplicity
P J Horan, K D Wild, A Misicka, et al.
Page
of 21